Dynavax Technologies Corp (DVAX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2929 SEVENTH STREET BERKELEY, CA 94710

Discovers, develops and intends to commercialize innovative products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases using proprietary approaches that alter immune system responses. Its clinical development programs are based on immunostimulatory sequences.

Data based on most recent fiscal year report
Market Cap1.109 Billion Shares Outstanding60.6 Million Avg Volume2.774 Million
1-Yr BETA vs S&P TR Current Ratio10.65 Quick Ratio10.64
View SEC Filings from DVAX instead.
Q1 2019 All Institutions Hedge Funds 1
To trade DVAX now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 134 22 (2.24%)
Aggregate 13F shares on 03/31/2019: 53.328 Million 13.386 Million
Aggregate 13F shares on 12/31/2018: 53.823 Million 15.825 Million
Percent change: -0.92% -15.41%
Funds creating new positions: 18 2
Funds Adding to an existing position: 52 12
Funds closing out their position: 11 3
Funds reducing their position: 31 3
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DVAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEW JENNIFER CHIEF FINANCIAL OFFICER

  • Officer
135,155 2019-05-01 0

COFFMAN ROBERT SENIOR VICE PRESIDENT

  • Officer
77,768 2019-02-28 4

OSTRACH MICHAEL S SENIOR VICE PRESIDENT

  • Officer
86,772 2019-02-28 5

NOVACK DAVID F SENIOR VICE PRESIDENT

  • Officer
56,554 2019-02-28 4

GRAY EDDIE CEO AND DIRECTOR

  • Officer
  • Director
229,597 2019-02-28 4

JOHNSON DAVID LOUIS VICE PRESIDENT

  • Officer
32,021 2019-02-28 6

JANSSEN ROBERT SENIOR VICE PRESIDENT

  • Officer
147,805 2019-02-22 3

BREGE LAURA

  • Director
0 2019-01-09 1

CANO FRANCIS

  • Director
172,636 2018-12-20 2

ORONSKY ARNOLD L

  • Director
0 2018-10-03 1

RICCIARDI NATALE S

  • Director
11,585 2018-07-31 1

KESSEL MARK

  • Director
0 2018-07-26 0

KISNER DANIEL L

  • Director
0 2018-06-21 1

PHILLIPS PEGGY V

  • Director
0 2018-05-31 1

CARSON DENNIS

  • Director
0 2018-05-31 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2017-07-14 0

PLOTKIN STANLEY A

  • Director
0 2017-06-02 0

LAWRENCE DAVID M

  • Director
0 2015-07-29 0

GILBERT DENISE

  • Director
0 2015-07-10 0

DINA DINO

  • Director
0 2014-05-28 0

TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS

  • Officer
0 2013-02-05 0

MARTIN J TYLER PRESIDENT, CMO & DIRECTOR

  • Officer
  • Director
222,089 2012-11-16 0

LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER

  • Officer
0 2012-08-13 0

JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE

  • Officer
0 2012-03-09 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • Director
  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
2,951,152 2011-09-26 0

BUC NANCY L

  • Director
0 2010-05-12 0

SYMPHONY CAPITAL PARTNERS LP

SYMPHONY CAPITAL GP, L.P.

SYMPHONY GP, LLC

SYMPHONY STRATEGIC PARTNERS LLC

TARANTO HARRI V

  • Director
  • 10% Owner
  • SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS
9,031,431 2010-04-16 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
25,254,628 2009-06-03 0

SMELTZER DEBORAH A VP, OPERATIONS & CFO

  • Officer
0 2009-03-10 0

SANDERS MARTIN E EVP AND CDO

  • Officer
0 2008-10-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments